Digital Biomarkers Through Connected Devices, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

High prevalence of complex diseases, high investments and low success rate associated with drug development, are making the health industry appeal for innovative technologies that can enhance understanding of complex diseases, contribute to the development of personalized treatments, accelerate clinical trial activities, and lower the R&D expenditure of healthcare companies.

Digital biomarkers are quantifiable physiological and behavioral data of a person, which are collected by digital devices, such as wearables and implants to predict health-related outcomes. Digital biomarkers offer a great opportunity to acquire clinically meaningful and objective data, to better understand variations in human health and diseases. Digital biomarkers can be collected cost-effectively by digital or connected tools such as smart watches, smart bands, and wireless sensors.

In this benchmarking study, the publisher has identified the top 12 key participants in the “Digital Biomarkers Through Connected Devices” space, as the leaders enabling the use of digital biomarkers in the healthcare industry.